Tamura M, Tsuchida Y, Kawano T, Honna T, Ishibashi R, Iwanaka T, Morita Y, Hashimoto H, Tada H, Miyasaka K
Department of Surgery, National Children's Hospital, Tokyo, Japan.
J Pediatr Surg. 1988 May;23(5):478-82. doi: 10.1016/s0022-3468(88)80453-6.
High frequency ventilation and extracorporeal membrane oxygenation (ECMO) are devices that are expected to save the lives of newborn infants whose pulmonary conditions have deteriorated. A piston-pump-type high-frequency oscillator (HFO), developed by Bryan and Miyasaka called "Hummingbird," is considered to be superior to high frequency "jet" ventilators or those of the flow-interrupter type, and was used successfully in two neonates with congenital diaphragmatic hernia (CDH) in a high-risk group. The first baby was on a conventional ventilator with pharmacologic support for the first 54 hours and then operated on. Postoperative deterioration necessitated the use of HFO for the next eight days. The infant then recovered uneventfully. For the second baby, HFO was necessary both preoperatively and postoperatively. This baby had a major diaphragmatic defect and her case was complicated with pneumothorax. There was a long stormy course on HFO (total, 70 days), but the patient was successfully extubated on the 75th day postoperatively and is now doing well. We believe active long preoperative stabilization with pharmacologic support and preoperative and postoperative hyperventilation with a piston-pump-type HFO may be a new innovative strategy for the management of severe CDH patients.
高频通气和体外膜肺氧合(ECMO)是有望挽救肺部状况恶化的新生儿生命的设备。由布莱恩(Bryan)和宫坂(Miyasaka)研发的名为“蜂鸟”的活塞泵式高频振荡器(HFO),被认为优于高频“喷射”呼吸机或气流中断型呼吸机,并成功用于两名高危组先天性膈疝(CDH)新生儿。第一个婴儿在最初54小时使用传统呼吸机并接受药物支持,然后接受手术。术后病情恶化,接下来八天需要使用HFO。婴儿随后顺利康复。对于第二个婴儿,术前和术后都需要使用HFO。这个婴儿有一个较大的膈肌缺损,并且病例并发气胸。在HFO上经历了漫长而波折的过程(总共70天),但患者在术后第75天成功拔管,目前情况良好。我们认为,术前积极进行长时间的药物支持稳定治疗以及术前和术后使用活塞泵式HFO进行过度通气,可能是管理严重CDH患者的一种新的创新策略。